The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. (Q48321719)

10 February 2018

title

The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. (English)

1 reference

10 February 2018

author name string

Cumberbatch MJ

series ordinal

1

1 reference

10 February 2018

Hill RG

series ordinal

2

1 reference

10 February 2018

Hargreaves RJ

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

European Journal of Pharmacology

published in

1 reference

10 February 2018

volume

362

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

43-46

1 reference

10 February 2018

Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Rizatriptan has central antinociceptive effects against durally evoked responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Mode of action of the anti-migraine drug sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

The concept of selectivity in 5-HT receptor research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900764-X

10.1016/S0014-2999(98)00764-X

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9865528

1 reference

10 February 2018